Legal Representation
Attorney
Alex Patel
USPTO Deadlines
Next Renewal Deadline
1278 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2009-01-06)
Due Date
January 06, 2029
Grace Period Ends
July 06, 2029
Application History
42 events| Date | Code | Type | Description |
|---|---|---|---|
| Aug 21, 2018 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Aug 21, 2018 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Aug 21, 2018 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Aug 21, 2018 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| Aug 10, 2018 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
| Jan 6, 2018 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Oct 13, 2016 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sep 21, 2016 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Jan 9, 2015 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Jan 9, 2015 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| Jan 9, 2015 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| Dec 24, 2014 | ES8R | I | TEAS SECTION 8 RECEIVED |
| May 30, 2012 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| May 20, 2012 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jan 6, 2009 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Dec 3, 2008 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED |
| Dec 2, 2008 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Nov 10, 2008 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Nov 10, 2008 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Nov 6, 2008 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Nov 6, 2008 | IUAF | S | USE AMENDMENT FILED |
| Aug 26, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Jun 3, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 14, 2008 | NPUB | O | NOTICE OF PUBLICATION |
| Apr 30, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 30, 2008 | ALIE | A | ASSIGNED TO LIE |
| Apr 30, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Apr 24, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Apr 23, 2008 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Apr 23, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Apr 8, 2008 | CNFR | R | FINAL REFUSAL WRITTEN |
| Apr 8, 2008 | GNFR | O | FINAL REFUSAL E-MAILED |
| Apr 8, 2008 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Mar 20, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 20, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 20, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 19, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 19, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 19, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 17, 2008 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 13, 2007 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED |
| Dec 12, 2007 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Medicines for human purposes for the treatment of dizziness, palpitation, insomnia, chagrin, nausea, numbness, back pain, flank pain; pharmaceutical ointments for the treatment of high blood pressure, hyperlipidemia, acute stroke, hemiplegia, cerebral infarct, residual defect of apoplexia, coronary artery disease, angina pectoris, myocarditis, cardiac arrhythmia; ginseng tea for pharmaceutical purposes for use in raising immunity, reducing the degree of aggregation of erythrocyte in blood, promoting blood circulation by removing blood stasis and preventing cardiovascular disease; cough syrups; roots and decoctions of herbs and resins for medical and pharmaceutical purposes; medicinal tea; medicinal herbs; substances in the form of extracts from plants and animals, dried plants, parts of plants, including roots, as well as other raw materials from plants or animals, used as drug and food supplements for healthcare and medicinal purpose; cachets for pharmaceutical purposes, namely, diet capsules, gelatin capsules sold empty for pharmaceuticals; pills for pharmaceutical purposes, namely, for the administration of pharmaceutical and chemico-pharmaceutical preparations in the nature of anaesthetics, analgesics and anti-irritant drugs, and preparations for the treatment of pain and drug dependency
First Use Anywhere:
Feb 6, 2008
First Use in Commerce:
Feb 6, 2008
Additional Information
Design Mark
The mark consists of A Ying Yang symbol with a leaf in the center.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005